Use of aprotinin during cardiopulmonary bypass in a patient with protein C deficiency

Journal of Extra-Corporeal Technology

Volumn 35, Issue 1, 2003, Pages 39-43

  Sievert, Alicia ^a,b   McCall, Mary ^a   Blackwell, Mindy ^a   Bradley, Scott ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aprotinin; Cardiopulmonary bypass; Protein C; Protein C deficiency; Trasylol

Indexed keywords

AMINOCAPROIC ACID; ANTITHROMBIN III; APROTININ; BLOOD CLOTTING FACTOR 5A; BLOOD CLOTTING FACTOR 8A; FRESH FROZEN PLASMA; HEPARIN; PLASMINOGEN ACTIVATOR INHIBITOR; PROTEIN C;

ADOLESCENT; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TIME; BLOOD FLOW; CARDIOPULMONARY BYPASS; CASE REPORT; COMPETITIVE INHIBITION; DEVICE; HEART ATRIOVENTRICULAR VALVE; HEART ATRIUM ARRHYTHMIA; HEART SINGLE VENTRICLE; HEART VALVE REGURGITATION; HEART VALVE REPLACEMENT; HEMOSTASIS; HOSPITAL DISCHARGE; HUMAN; HYPERCOAGULABILITY; MALE; OPEN HEART SURGERY; POSTOPERATIVE COMPLICATION; PROTEIN C DEFICIENCY; REOPERATION; THROMBOELASTOGRAPHY; THROMBOSIS;

EID: 0037342740     PISSN: 00221058     EISSN: 29698960     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Lee G, Forester J, Lukens J, Paraskevus F, Rodgers G. Wintrobes Clinical Hematology, 10th ed. Philadelphia: Lippincott Williams & Wilkins, 1999.
2. National Institution of Medicine. Medline Plus Health Line. 2002. http://www.nlm.nih.gov/medlineplus/ency/article/003659.htm.
3. Urbana/Champaign and Carle Cancer Center. Protein C Deficiency., www-admin.med.uiuc.edu/hematology
4. Kavehmanesh Z, Abolghasemi H, Matinzadeh ZK. Neonatal purpura fulminans in a neonate with protein C deficiency. J Med Science. 2000:25:169-71.
5. Ridley PD, Ledingham SJ, Lennox SC, et al. Protein C deficiency associated with massive cerebral thrombosis following open-heart surgery. J Cardiovasc Surg. 1990;31:249-51.
6. Lawson, S, Darling EM, Ware RE, Kern FH, Ungerleider RM, Shearer IR. Management considerations for a heterozygous protein C deficient patient undergoing open-heart surgery with cardiopulmonary bypass. J Extra Corp Tech. 1995;27:172-6.
7. Grimmet R, Beck J, Chan R. Cardiopulmonary bypass management of a patient with protein C and protein S deficiency. Proceed Am Acad Cardiovasc Perf. 2001;22:151-2.
8. Espana F, Estekkes A, Griffin JH, Aznar J, Gilabert J. Aprotinin (trayslol) is a competitive inhibitor of activated protein C. Thrombolytic Res. 1989;56:751-6.
9. Kapural L, Sprung J. Perioperative management and use of anticoagulants and fibrinolytics. Anesthes Clin N Am. 1999;17:923-58.
10. Speekenbrink RG, Bertina RM, Espana F, et al. Activation of the protein C system during cardiopulmonary bypass with and without aprotinin. Ann Thorac Surg. 1998;66:1998-2002.
11. Spanier TB, Chen JM, Mancini DM, Smith CR, Edwards NM. Cardiac transplantation in a patient with protein S deficiency. Ann Thorac Surg. 1999;68:1078-80.
12. Van Norman GA. Effects of hemofiltration on serum aprotinin levels in patients undergoing cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2000;14:253-6.